miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
| Author | |
|---|---|
| Abstract | :
High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related to HCC metastasis. Whether the expression of miR-182-5p in tumor tissue correlated with early recurrence in HCC patients underwent curative surgery was unknown. |
| Year of Publication | :
2018
|
| Journal | :
Journal of hematology & oncology
|
| Volume | :
11
|
| Issue | :
1
|
| Number of Pages | :
12
|
| Date Published | :
2018
|
| URL | :
https://jhoonline.biomedcentral.com/articles/10.1186/s13045-018-0555-y
|
| DOI | :
10.1186/s13045-018-0555-y
|
| Short Title | :
J Hematol Oncol
|
| Download citation |